52.91
+0.91(+1.75%)
Currency In USD
| Previous Close | 52 |
| Open | 50.52 |
| Day High | 53.62 |
| Day Low | 50.2 |
| 52-Week High | 56.77 |
| 52-Week Low | 18.99 |
| Volume | 702,547 |
| Average Volume | 688,319 |
| Market Cap | 2.02B |
| PE | -14.11 |
| EPS | -3.75 |
| Moving Average 50 Days | 45.86 |
| Moving Average 200 Days | 34.84 |
| Change | 0.91 |
If you invested $1000 in Tarsus Pharmaceuticals, Inc. (TARS) since IPO date, it would be worth $2,570.94 as of December 21, 2024 at a share price of $52.91. Whereas If you bought $1000 worth of Tarsus Pharmaceuticals, Inc. (TARS) shares 3 years ago, it would be worth $1,968.38 as of December 21, 2024 at a share price of $52.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
GlobeNewswire Inc.
Nov 13, 2024 1:30 PM GMT
Humana CMO brings more than two decades of experience driving innovative, value-based initiatives designed to improve patient outcomes IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is t
Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
GlobeNewswire Inc.
Nov 06, 2024 9:30 PM GMT
IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, tod
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
GlobeNewswire Inc.
Nov 05, 2024 1:30 PM GMT
Dr. Yeu transitions from her role as Chief Medical Advisor and Board Member to lead the Company’s newly created Medical Organization Elizabeth Yeu, M.D., Chief Medical Officer, Tarsus Elizabeth Yeu, M.D., Chief Medical Officer, Tarsus IRVINE, Cali